AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇿🇦
Enzalutamide in South Africa
8 products registered with SAHPRA — 8 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| NUXTAND | 56/26/0920 | Cipla Medpro (Pty) Ltd | active | 14 Mar 2028 |
| XZALU | 56/26/0921.920 | Cipla Medpro (Pty) Ltd | active | 14 Mar 2028 |
| ENZALUTAMIDE 40 mg CIPLA | 55/26/0833 | Cipla Medpro (Pty) Ltd | active | 7 Feb 2028 |
| ENZUTIX | 55/26/0125 | Eurolab (Pty) Ltd | active | 24 Jan 2028 |
| DIZALET | 55/26/0174 | Aurogen South Africa (Pty) Ltd | active | 1 Jan 1900 |
| DIZALUM | 55/26/0175.174 | Aurogen South Africa (Pty) Ltd | active | 1 Jan 1900 |
| ZILADE | 55/26/0176.174 | Aurogen South Africa (Pty) Ltd | active | 1 Jan 1900 |
| XTANDI 40 mg | 48/26/0404 | Astellas Pharma (Pty) Ltd | active | 1 Jan 1900 |
Enzalutamide — SAHPRA Registration Details
SAHPRA (South Africa) has 8 registered products containing Enzalutamide, of which 8 are currently active. Data is sourced directly from the official SAHPRA drug register and refreshed daily.
Track Enzalutamide registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.